Post
Experts say femtech funding booming despite wider investment downturn
The femtech sector is going from strength to strength, despite the weaker investment landscape throughout the healthcare industry, experts say. Panellists …
Signal: Absci and AstraZeneca sign deal on AI-powered cancer antibody drug
Pharmaceuticals giant AstraZeneca has closed on a deal with US-based biotech Absci Corporation to develop an antibody therapy for an …
Q+A: Roche’s Nicole Arming and Stefano Volonté on personalised medicine’s potential
Personalised medicine is generating significant interest in the healthcare industry as standard blanket approaches to patient therapies metamorphose into individualised …
Qnovia’s inhaled smoking cessation therapy triumphs in first clinical study
Pharmaceutical company, Qnovia has shared positive results from initial clinical trials of its prescription inhaled smoking cessation therapy. The drug delivery …
Game changing: How AI and automation is revolutionising clinical trial admin
In the wake of COVID-19, clinical trials deserve our attention more than ever. If there’s one thing to be learned …
Pharma industry groups push initiatives against climate change at COP28
Several pharmaceutical industry advocacy and lobby organisations have bandied together to release a joint industry statement supporting the Declaration on …
Experts say femtech funding booming despite wider investment downturn
The femtech sector is going from strength to strength, despite the weaker investment landscape throughout the healthcare industry, experts say. Panellists …
Signal: Absci and AstraZeneca sign deal on AI-powered cancer antibody drug
Pharmaceuticals giant AstraZeneca has closed on a deal with US-based biotech Absci Corporation to develop an antibody therapy for an …
Q+A: Roche’s Nicole Arming and Stefano Volonté on personalised medicine’s potential
Personalised medicine is generating significant interest in the healthcare industry as standard blanket approaches to patient therapies metamorphose into individualised …
Qnovia’s inhaled smoking cessation therapy triumphs in first clinical study
Pharmaceutical company, Qnovia has shared positive results from initial clinical trials of its prescription inhaled smoking cessation therapy. The drug delivery …
Game changing: How AI and automation is revolutionising clinical trial admin
In the wake of COVID-19, clinical trials deserve our attention more than ever. If there’s one thing to be learned …
Robot glove for stroke patients receives £435k boost from Innovate UK
An Edinburgh start-up, based out of the National Robotarium, has been awarded £435,000 ($570,000) to accelerate its robotic glove aimed …
SCARS Center selects SciBase’s Nevisense system to detect skin cancer
The Skin and Cancer Reconstructive Surgery Center (SCARS Center) in California, US, has selected SciBase Holding’s Nevisense system for the …
Colibri’s valve shows superior haemodynamics in pilot study
Colibri Heart Valve announced that the transcatheter aortic valve (TAVR) pilot study in the European Union (EU) has shown superior …
Lack of women’s data is causing femtech start ups to lose out on VC funding
The length of time needed for femtech startups to conduct studies to support their technologies is deterring venture capital (VC) …